French Toast Crunch
A breakfast cereal inspired by French toast
This article is about the breakfast cereal. For the food, see French toast.
Overview
French Toast Crunch is a breakfast cereal manufactured by General Mills. It was first introduced in 1996 and is known for its unique shape and flavor, which mimics the taste of French toast. The cereal pieces are shaped like miniature slices of toast and are coated with a sweet, cinnamon-flavored sugar.
History
French Toast Crunch was launched in 1996 as a spin-off of the popular Cinnamon Toast Crunch cereal. It was initially well-received due to its distinctive flavor and nostalgic appeal. However, in 2006, General Mills discontinued the cereal in the United States, citing a shift in consumer preferences.
In response to consumer demand and a strong online fan base, General Mills reintroduced French Toast Crunch to the U.S. market in 2014. The relaunch was met with enthusiasm from fans who had missed the cereal's unique taste and texture.
Ingredients and Nutrition
French Toast Crunch is made from whole grain corn, sugar, corn syrup, and a blend of spices that give it its signature French toast flavor. The cereal is fortified with vitamins and minerals, including iron, calcium, and vitamin D.
Nutritional Information
A typical serving of French Toast Crunch contains approximately 120 calories, 3 grams of fat, 22 grams of carbohydrates, and 1 gram of protein. It is also a source of dietary fiber and contains added vitamins and minerals.
Cultural Impact
French Toast Crunch has developed a cult following over the years, with many fans expressing nostalgia for the cereal on social media and online forums. Its reintroduction in 2014 was largely driven by consumer demand and the power of online petitions.
The cereal is often associated with the 1990s and early 2000s, a period when many unique and innovative cereals were introduced to the market. French Toast Crunch is frequently mentioned in discussions about "nostalgia marketing" and the revival of discontinued products.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD